Compare ALEMBIC LTD with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs NATCO PHARMA - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD NATCO PHARMA ALEMBIC LTD/
NATCO PHARMA
 
P/E (TTM) x 62.4 22.8 273.8% View Chart
P/BV x 2.5 3.6 70.9% View Chart
Dividend Yield % 0.4 0.9 42.6%  

Financials

 ALEMBIC LTD   NATCO PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
NATCO PHARMA
Mar-19
ALEMBIC LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs72849 8.5%   
Low Rs34557 6.1%   
Sales per share (Unadj.) Rs4.7573.8 0.8%  
Earnings per share (Unadj.) Rs6.1176.0 3.5%  
Cash flow per share (Unadj.) Rs6.2198.2 3.2%  
Dividends per share (Unadj.) Rs0.206.25 3.2%  
Dividend yield (eoy) %0.40.9 42.5%  
Book value per share (Unadj.) Rs40.7842.7 4.8%  
Shares outstanding (eoy) m267.0336.50 731.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x11.31.2 919.5%   
Avg P/E ratio x8.74.0 217.2%  
P/CF ratio (eoy) x8.53.5 239.0%  
Price / Book Value ratio x1.30.8 156.1%  
Dividend payout %3.33.6 92.3%   
Avg Mkt Cap Rs m14,13925,660 55.1%   
No. of employees `000NA5.0 0.0%   
Total wages/salary Rs m2073,559 5.8%   
Avg. sales/employee Rs ThNM4,225.3-  
Avg. wages/employee Rs ThNM718.0-  
Avg. net profit/employee Rs ThNM1,295.9-  
INCOME DATA
Net Sales Rs m1,25520,945 6.0%  
Other income Rs m3701,302 28.4%   
Total revenues Rs m1,62522,247 7.3%   
Gross profit Rs m1117,948 1.4%  
Depreciation Rs m38810 4.7%   
Interest Rs m2193 0.9%   
Profit before tax Rs m4428,247 5.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m241,823 1.3%   
Profit after tax Rs m1,6306,424 25.4%  
Gross profit margin %8.937.9 23.3%  
Effective tax rate %5.422.1 24.5%   
Net profit margin %129.830.7 423.4%  
BALANCE SHEET DATA
Current assets Rs m1,86723,472 8.0%   
Current liabilities Rs m5917,287 8.1%   
Net working cap to sales %101.677.3 131.5%  
Current ratio x3.23.2 98.0%  
Inventory Days Days9492 102.2%  
Debtors Days Days7488 83.4%  
Net fixed assets Rs m1,79118,648 9.6%   
Share capital Rs m534365 146.3%   
"Free" reserves Rs m10,32434,525 29.9%   
Net worth Rs m10,85830,760 35.3%   
Long term debt Rs m410-   
Total assets Rs m11,59143,031 26.9%  
Interest coverage x260.943.7 596.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.10.5 22.2%   
Return on assets %14.115.4 91.5%  
Return on equity %15.020.9 71.9%  
Return on capital %15.227.4 55.4%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1911,536 0.2%   
Fx outflow Rs m2642,939 9.0%   
Net fx Rs m-2448,597 -2.8%   
CASH FLOW
From Operations Rs m2366,688 3.5%  
From Investments Rs m-224-6,122 3.7%  
From Financial Activity Rs m-27-509 5.2%  
Net Cashflow Rs m-1566 -22.4%  

Share Holding

Indian Promoters % 64.0 52.0 123.0%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.2 7.8 2.6%  
FIIs % 9.7 16.6 58.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 26.0 100.4%  
Shareholders   54,701 25,395 215.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   IPCA LABS  SANOFI INDIA  DR. DATSONS LABS  PROCTER & GAMBLE HEALTH  NOVARTIS  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 202 Points Lower; Oil & Gas and Power Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day on a negative note. At the closing bell, the BSE Sensex stood lower by 202 points.

Related Views on News

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Buy this 'Crorepati Stock' and You Could End Up Stinking Rich(Profit Hunter)

Feb 5, 2020

I'm talking about an individual small cap stock that could go up so many times that they make their investors stinking rich in the process. You definitely want to know more...

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years)(Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Will Your Trade Go Up or Down Today?(Fast Profits Daily)

Feb 5, 2020

How you can find out which way your trade is likely to move on any given trading day.

Will Algo Traders Take Away All Your Profits?(Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

No Change in My Long-Term View on the Rebirth of India Stocks(The 5 Minute Wrapup)

Feb 6, 2020

Why the recent post budget volatility has not affected my bullish view on the Rebirth of India stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 17, 2020 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS